Raptor Pharmaceutical to Hold Second Quarter 2014 Financial Results Webcast and Conference Call
July 28, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release second quarter 2014 financial results after market close on Thursday,...
Raptor Announces CEO Succession Plan; Dr. Christopher Starr to Retire as CEO at Year-end 2014, Julie Anne Smith Named President and CEO-Designate
July 07, 2014 16:01 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 7, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceuticals (Nasdaq:RPTP) today announced that Julie Anne Smith, Executive Vice President, Strategy and Chief Operating Officer at Raptor,...
Raptor Pharmaceutical Enters Into $70 Million Financing Transaction and Amended Loan Agreement With HealthCare Royalty Partners
July 01, 2014 17:13 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has entered into agreements for $70 million in funding from HealthCare Royalty...
Data Published in Journal of Pediatrics Demonstrated That PROCYSBI(R) Improved Quality of Life and Preserved Kidney Function in Cystinosis Patients
June 24, 2014 07:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that data from its open label extension study of delayed-release cysteamine bitartrate...
Raptor Pharmaceutical to Participate in Three Upcoming Investor Conferences in June
June 10, 2014 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., June 10, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will participate in three upcoming investor conferences in...
Raptor Pharmaceutical Reports First Quarter 2014 Financial Results and Provides Corporate Update
May 08, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
Reports PROCYSBI® net product sales of $12.1 million in first quarter 2014 and launch of PROCYSBI® in Germany
Company to host conference call and webcast today at 4:30 p.m. EDT...
Raptor Pharmaceutical to Present at Upcoming Investor Conference
May 01, 2014 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Bank of America Merrill Lynch 2014 Health Care...
Raptor Pharmaceutical to Hold First Quarter 2014 Financial Results Webcast and Conference Call
April 30, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release first quarter 2014 financial results after market close on Thursday,...
Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Corporate Update
March 13, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
2014 guidance of $55-$65 million of net sales for PROCYSBI®
Company to host conference call and webcast today at 4:30 p.m. EDT
NOVATO, Calif., March 13, 2014 (GLOBE NEWSWIRE) -- Raptor...
Raptor Pharmaceutical to Hold Fourth Quarter and Full Year 2013 Financial Results Webcast and Conference Call
March 10, 2014 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., March 10, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release fourth quarter and full year 2013 financial results after market close...